These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Effects of exogenous surfactants on mortality and main complications of hyaline membrane disease]. Walti H, Relier JP. Pediatrie; 1990 Feb; 45(10):657-63. PubMed ID: 2177543 [Abstract] [Full Text] [Related]
3. [Hyaline membrane disease in the premature infant: diagnostic aspects and therapeutic prospects (excluding mechanical ventilation)]. Dehan M. Rev Prat; 1989 Sep 21; 39(21):1844-8. PubMed ID: 2814266 [Abstract] [Full Text] [Related]
4. [Pulmonary hyaline membranes in newborn infants. (Idiopathic respiratory distress syndrome)]. Göcke H, Bienengräber A. Zentralbl Chir; 1974 Aug 23; 99(34):1057-61. PubMed ID: 4613061 [No Abstract] [Full Text] [Related]
5. [Factors increasing susceptibility to neonatal hyaline membrane syndrome and its prevention. I. Deficiency of surfactant and glucocorticoid treatment]. Uszyńska-Folejewska R, Uszyński M. Pediatr Pol; 1977 Dec 23; 52(12):1413-7. PubMed ID: 343058 [No Abstract] [Full Text] [Related]
11. [Exogenous surfactants in infants. Indications and limitations]. Voyer M, Magny JF. Presse Med; 1993 Feb 13; 22(5):194-6. PubMed ID: 8511131 [No Abstract] [Full Text] [Related]
12. [Critical study of the use of glucocorticoids in the prevention of hyaline membrane disease]. Leroy JL. J Gynecol Obstet Biol Reprod (Paris); 1982 Feb 13; 11(1):152-7. PubMed ID: 6896522 [No Abstract] [Full Text] [Related]
13. [Exogenous surfactants in neonatology]. Zupan V, Meric M, Dehan M. Rev Mal Respir; 1995 Feb 13; 12(6):642-5. PubMed ID: 8677364 [No Abstract] [Full Text] [Related]
14. [Exogenous surfactants. Indications and limits in 1992]. Voyer M, Laudat F, Kochert F, Zeller J. Arch Fr Pediatr; 1992 Apr 13; 49 Suppl 1():237-9. PubMed ID: 1449366 [No Abstract] [Full Text] [Related]
15. [Lung coating with surface-active material using the ultrasonic nebulizer]. Benzer H, Baum M, Tölle W. Z Erkr Atmungsorgane Folia Bronchol; 1971 Apr 13; 135(3):353-7. PubMed ID: 5211713 [No Abstract] [Full Text] [Related]
16. [Hydrocortisone in prevention of originating hyaline membranes (author's transl)]. Dluholucký S, Taufer I, Babic J, Kapusta D. Cesk Gynekol; 1974 Jul 13; 39(5):342-4. PubMed ID: 4407970 [No Abstract] [Full Text] [Related]
17. [Importance of the "surfactant system" in the pathogenesis of hyaline membrane in the newborn]. Cosmi EV, Condorelli S, Scarpelli EM. Acta Anaesthesiol; 1970 Jul 13; 31():Suppl:69-94. PubMed ID: 5538013 [No Abstract] [Full Text] [Related]
18. [Administration of surfactant in hyaline membrane disease]. Valls i Soler A. An Esp Pediatr; 1987 Sep 13; 27(3):147-51. PubMed ID: 3322119 [No Abstract] [Full Text] [Related]
19. Pulmonary surfactant replacement in respiratory distress syndrome. Vidyasagar D, Shimada S. Clin Perinatol; 1987 Dec 13; 14(4):991-1015. PubMed ID: 3322633 [Abstract] [Full Text] [Related]
20. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease]. Lozano-González CH, Piña-Ceballos VM, Beyer-Obezo J, Gutiérrez-Martín A, Martínez-Hinojosa B, Flores-Támez ME. Bol Med Hosp Infant Mex; 1993 Jul 13; 50(7):481-91. PubMed ID: 8363747 [Abstract] [Full Text] [Related] Page: [Next] [New Search]